In a recent study published in Journal of the American Geriatrics Society, Veterans with housing instability were 53% more likely to receive a diagnosis of Alzheimer’s disease or a related dementia (ADRD) than those with stable housing.
Xspray Pharma handed CRL from US regulators seeking more information about leukemia treatment
Xspray Pharma has been given a complete response letter from the FDA over the NDA for its leukemia treatment Dasynoc, which it had expected to
July 12, 2023